Literature DB >> 21330076

Transmucosal O2 and CO2 exchange rates for the human middle ear.

William J Doyle1, J Douglas Swarts, Juliane Banks, Sancak Yuksel, Cuneyt M Alper.   

Abstract

OBJECTIVE: Estimate the transmucosal CO(2) and O(2) rate-constants for adult middle ears (MEs).
METHODS: Ten adults with healthy MEs had a unilateral myringotomy. A custom-fitted acrylic mold with a valved line to a mass spectrometer (MS) and central tube coupled to a 3-way valve and connected to a pressure transducer (the probe) was sealed with adhesive glue within the ipsilateral ear-canal. A second 3-way valve was attached to the probe valve, a flow-regulated tank gas source and paired syringes. Volumes of the ME and probe were measured. On sequential days, the probe+ME was washed for 15-min with 6% O(2), Balance N(2) and 25% O(2), 6% CO(2), Balance N(2) to create transmucosal CO(2) and O(2) gradients, respectively. After washing, the probe+ME was isolated from the gas source, and baseline and 10-min gas samples were obtained for MS analysis of gas partial-pressures. The rates of change in ME CO(2) and O(2) pressures were divided by their established transmucosal gradients to yield CO(2) and O(2) rate-constants.
RESULTS: The average (±STD) transmucosal CO(2) and O(2) rate-constants were 0.062 ± 0.034 (N=10, range: 0.032-0.119) and 0.011 ± 0.009 (N=8, range: 0.002-0.032)mmHg/min/mmHg, respectively. The average half-life for the CO(2) and O(2) gradient was 11.1 and 61.6 min. The average CO(2):O(2) rate-constant ratio was 8.1 ± 4.0 (N=8, range: 3.6-14.6).
CONCLUSIONS: For adult human MEs, transmucosal CO(2) exchange is rapid and much faster than transmucosal O(2) exchange. The estimated CO(2)/O(2) rate-constant ratio for the human ME is not consistent with that predicted for diffusion-limited gas exchange across a water-based barrier.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21330076      PMCID: PMC3132822          DOI: 10.1016/j.anl.2011.01.006

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  20 in total

1.  Mathematical model explaining the sources of error in certain estimates of the gas exchange constants for the middle ear.

Authors:  W J Doyle
Journal:  Ann Otol Rhinol Laryngol       Date:  2000-06       Impact factor: 1.547

2.  Middle ear gas exchange via the mucosa: estimation by hyperventilation.

Authors:  Fumio Ikarashi; Akio Tsuchiya
Journal:  Acta Otolaryngol       Date:  2008-01       Impact factor: 1.494

3.  Positive intratympanic pressure in the morning and its etiology.

Authors:  H Shinkawa; T Okitsu; T Yusa; M Yamamuro; Y Kaneko
Journal:  Acta Otolaryngol Suppl       Date:  1987

4.  Regulation of negative middle ear pressure without tubal opening.

Authors:  L Hergils; B Magnuson
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1988-12

Review 5.  Anatomy and physiology of eustachian tube and middle ear related to otitis media.

Authors:  C D Bluestone; W J Doyle
Journal:  J Allergy Clin Immunol       Date:  1988-05       Impact factor: 10.793

6.  Gas exchange across the middle ear mucosa in monkeys. Estimation of exchange rate.

Authors:  W J Doyle; J T Seroky; C M Alper
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1995-08

7.  Inert gas exchange in the middle ear.

Authors:  A Ranade; C J Lambertsen; A Noordergraaf
Journal:  Acta Otolaryngol Suppl       Date:  1980

8.  Morning pressure in the middle ear.

Authors:  L Hergils; B Magnuson
Journal:  Arch Otolaryngol       Date:  1985-02

9.  Human middle ear gas composition studied by mass spectrometry.

Authors:  L Hergils; B Magnuson
Journal:  Acta Otolaryngol       Date:  1990 Jul-Aug       Impact factor: 1.494

10.  Middle ear gas exchange in rhesus monkeys.

Authors:  W J Doyle; J T Seroky
Journal:  Ann Otol Rhinol Laryngol       Date:  1994-08       Impact factor: 1.547

View more
  1 in total

1.  A formal description of middle ear pressure-regulation.

Authors:  William J Doyle
Journal:  Hear Res       Date:  2017-08-24       Impact factor: 3.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.